Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1985 1
1986 1
1988 1
1990 1
1991 2
1992 1
1995 2
1996 1
1997 3
1999 3
2000 2
2001 6
2002 3
2003 2
2004 6
2005 5
2006 3
2007 10
2008 8
2009 11
2010 11
2011 21
2012 18
2013 15
2014 17
2015 20
2016 18
2017 16
2018 17
2019 15
2020 20
2021 29
2022 23
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

277 results

Results by year

Filters applied: . Clear all
Page 1
Intratumoral CD103(+) CD8(+) T cells predict response to neoadjuvant chemoimmunotherapy in advanced head and neck squamous cell carcinoma.
Ren S, Lan T, Wu F, Chen S, Jiang X, Huo C, Li Z, Xie S, Wu D, Wang R, Li Y, Qiu L, Huang G, Li S, Wang X, Cen M, Cai T, Lin Z, Li J, Li B. Ren S, et al. Cancer Commun (Lond). 2023 Oct;43(10):1143-1163. doi: 10.1002/cac2.12480. Epub 2023 Sep 1. Cancer Commun (Lond). 2023. PMID: 37658605 Free PMC article.
The efficacy of NACI needs to be potentiated by identifying accurate biomarkers to predict clinical responses. Here, we attempted to identify molecules predicting NACI response in advanced HNSCC. ...Further receiver operating characteristic curve analysis defined th …
The efficacy of NACI needs to be potentiated by identifying accurate biomarkers to predict clinical responses. Here, we attempted to …
A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.
Schinke H, Shi E, Lin Z, Quadt T, Kranz G, Zhou J, Wang H, Hess J, Heuer S, Belka C, Zitzelsberger H, Schumacher U, Genduso S, Riecken K, Gao Y, Wu Z, Reichel CA, Walz C, Canis M, Unger K, Baumeister P, Pan M, Gires O. Schinke H, et al. Mol Cancer. 2022 Sep 8;21(1):178. doi: 10.1186/s12943-022-01646-1. Mol Cancer. 2022. PMID: 36076232 Free PMC article.
However, response to EGFR treatment is inconsistent and lacks markers for treatment prediction. This study investigated EGFR-induced epithelial-to-mesenchymal transition (EMT) as a central parameter in tumor progression and identified novel prognostic and therapeuti …
However, response to EGFR treatment is inconsistent and lacks markers for treatment prediction. This study investigated EGFR-induced …
Prognostic and Predictive Factors in Advanced Head and Neck Squamous Cell Carcinoma.
Magnes T, Wagner S, Kiem D, Weiss L, Rinnerthaler G, Greil R, Melchardt T. Magnes T, et al. Int J Mol Sci. 2021 May 7;22(9):4981. doi: 10.3390/ijms22094981. Int J Mol Sci. 2021. PMID: 34067112 Free PMC article. Review.
Despite multimodality treatments approximately half of all patients with locally advanced disease relapse and the prognosis of patients with recurrent or metastatic HNSCC is dismal. ...However, approximately only one third of unselected patients respond to this combination …
Despite multimodality treatments approximately half of all patients with locally advanced disease relapse and the prognosis of patien …
Six-MicroRNA Prognostic Signature in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma.
Worakitchanon W, Panvongsa W, Siripoon T, Kitdumrongthum S, Wongpan A, Arsa L, Trachu N, Jinawath N, Chairoungdua A, Ngamphaiboon N. Worakitchanon W, et al. JCO Precis Oncol. 2023 May;7:e2300003. doi: 10.1200/PO.23.00003. JCO Precis Oncol. 2023. PMID: 37163716
In multivariate analysis, the six-miRNA signature was an independent prognostic factor for OS in the RA cohort (HR, 1.958; 95% CI, 1.006 to 3.812; P = .048). CONCLUSION: We identified a prognostic six-miRNA signature for patients with LA-HNSCC from TCGA cohort and v …
In multivariate analysis, the six-miRNA signature was an independent prognostic factor for OS in the RA cohort (HR, 1.958; 95% CI, 1. …
EGFR monoclonal antibodies in locally advanced head and neck squamous cell carcinoma: What is their current role?
Alorabi M, Shonka NA, Ganti AK. Alorabi M, et al. Crit Rev Oncol Hematol. 2016 Mar;99:170-9. doi: 10.1016/j.critrevonc.2015.12.006. Epub 2015 Dec 19. Crit Rev Oncol Hematol. 2016. PMID: 26797287 Review.
The epidermal growth factor receptor (EGFR) is over-expressed in nearly 80-90% of cases of SCCHN and correlates with poor prognosis and resistance to radiation. Preclinical evidence showed that blocking EGFR restores radiation sensitivity and enhances cytotoxicity. ...
The epidermal growth factor receptor (EGFR) is over-expressed in nearly 80-90% of cases of SCCHN and correlates with poor prognosis a …
Any place left for induction chemotherapy for locally advanced head and neck squamous cell carcinoma?
Burgy M, Leblanc J, Borel C. Burgy M, et al. Anticancer Drugs. 2018 Apr;29(4):287-294. doi: 10.1097/CAD.0000000000000595. Anticancer Drugs. 2018. PMID: 29420335 Review.
This review summarizes the major studies with their limits and discusses how the ICT could improve the patients' prognosis in the future....
This review summarizes the major studies with their limits and discusses how the ICT could improve the patients' prognosis in the fut …
Induction Chemotherapy for Advanced Oral Cavity Cancer.
de Oliveira TB, Marta GN, de Castro Junior G, Kowalski LP. de Oliveira TB, et al. Curr Oncol Rep. 2021 Aug 27;23(11):129. doi: 10.1007/s11912-021-01119-6. Curr Oncol Rep. 2021. PMID: 34453267 Review.
PURPOSE OF REVIEW: Head and neck cancer is a heterogeneous disease, comprising multiple subsites with diverse etiologic factors, pathology and molecular features, response to treatment, and prognosis. Systemic treatment is usually incorporated in the management of locally …
PURPOSE OF REVIEW: Head and neck cancer is a heterogeneous disease, comprising multiple subsites with diverse etiologic factors, pathology a …
277 results